NeurogesX brings in extra help lining up a new partnership; OxfordBioMedica shares surge on Parkinson's data; ImmunoGen launches PhI;

 @FierceBiotech: UCLA morphs stem cells into T-cell missiles that seek out and destroy HIV. Story | Follow @FierceBiotech

 @JohnCFierce: Note to China: Gotta watch out for those chromium-laced drug capsules. More | Follow @JohnCFierce

 @RyanMFierce: David Steinberg sheds light on where the open access movement could lead us: Scientific Hive Mind. Piece | Follow @RyanMFierce

> Forced to restructure the company after the FDA recently slapped down its application to expand the use of Qutenza, NeurogesX ($NGSX) has brought in a consultant to see if it can help line up a partner to develop its lead product candidate NGX-1998 as well as the pain patch. Release

> Shares of Oxford BioMedica surged on the positive results reported for its Parkinson's drug ProSavin. Story

> ImmunoGen says it has launched a Phase I escalating-dose study of IMGN529 in patients with non-Hodgkin lymphoma. Release

> Dyax ($DYAX) and Eclipse have inked a licensing deal for antibodies discovered using Dyax's phage display technology. Release

Pharma News

@FiercePharma: Glaxo CFO Simon Dingemans tells IBD about "in-sourcing" previously farmed-out manufacturing (and more). Article | Follow @FiercePharma

> Supreme Court zeroes in on pharma reps' OT claims. Article

> Chinese regulators freeze sales of drugs with toxic capsules. News

Medical Devices News

@FierceMedDev: Brainsway in breakthrough for depression treatment--Globes. Report  | Follow @FierceMedDev

> Medtronic to start trial of Admiral drug-eluting balloon. More

> New tech reduces cell death in TBI rat study. News

> Cordis appeals $40M award to Boston Sci. Item

Pharma Manufacturing News

> South Africa creates list of drugs it will buy only if they are made there. News

> Samsung says its manufacturing 'DNA' will provide big biosimilar savings. More

> China investigates 43 drug manufacturers tied to adulterated drug capsules. Story

> Innovative construction project boosts Merck's Zostavax manufacturing. Article

Biotech Research News

> Surging research in Asia is an opportunity for us. Piece

> Drug derived from Chinese herb aided brain tumor-stricken mice. Story

> UCLA morphs stem cells into T-cell missiles that seek and destroy HIV. Article

> Drug tackles Fragile X/autism symptoms in mice. News

And Finally… Investigators in Norway say that omega-3 supplements failed to demonstrate any benefits for patients with multiple sclerosis. Story

Suggested Articles

In our EuroBiotech roundup this week, Azeria raises £32 million, Zealand delays phase 3 readout and Galapagos eyes early 2021 IPF futility analysis. 

After the loss of its longtime CEO at the start of the year, a morphing MorphoSys is now losing its CSO.

A new study shows how circular ecDNA outside of the chromosome in cancer cells drives oncogenes, making tumors more aggressive.